Anagenics Ltd (ASX: AN1) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Anagenics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$5.91 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
985.45 million
Earnings per share
-0.003
Dividend per share
N/A
Year To Date Return
20.00%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Anagenics Ltd (ASX: AN1)
Latest News
No posts found.
AN1 ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Anagenics Ltd
Anagenics Ltd. operates as a biotechnology company, which engages in the development and marketing of therapies and diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart, and hair loss. The company was founded on October 8, 2004 and is headquartered in Sydney, Australia.
AN1 Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 18 Feb 2026 | $0.01 | $0.00 | 0.00% | 1,140,000 | $0.01 | $0.01 | $0.01 |
| 17 Feb 2026 | $0.01 | $0.00 | 0.00% | 3,004,250 | $0.01 | $0.01 | $0.01 |
| 16 Feb 2026 | $0.01 | $0.00 | 0.00% | 4,000 | $0.01 | $0.01 | $0.01 |
| 13 Feb 2026 | $0.01 | $0.00 | 0.00% | 99,532 | $0.01 | $0.01 | $0.01 |
| 12 Feb 2026 | $0.01 | $0.00 | 0.00% | 277,500 | $0.01 | $0.01 | $0.01 |
| 10 Feb 2026 | $0.01 | $0.00 | 0.00% | 299,215 | $0.01 | $0.01 | $0.01 |
| 03 Feb 2026 | $0.01 | $0.00 | 0.00% | 880,206 | $0.01 | $0.01 | $0.01 |
| 02 Feb 2026 | $0.01 | $0.00 | 0.00% | 350,000 | $0.01 | $0.01 | $0.01 |
| 30 Jan 2026 | $0.01 | $0.00 | 0.00% | 221,000 | $0.01 | $0.01 | $0.01 |
| 27 Jan 2026 | $0.01 | $0.00 | 0.00% | 20,200 | $0.01 | $0.01 | $0.01 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 16 May 2025 | Alexander (Sandy) Beard | Buy | 55,564 | $336 |
On-market trade.
|
| 14 May 2025 | Alexander (Sandy) Beard | Buy | 5 | $0 |
On-market trade.
|
| 12 May 2025 | Alexander (Sandy) Beard | Buy | 226,876 | $1,373 |
On-market trade.
|
| 08 May 2025 | Alexander (Sandy) Beard | Buy | 267,555 | $1,619 |
On-market trade.
|
| 07 May 2025 | Alexander (Sandy) Beard | Buy | 1,950,000 | $14,337 |
On-market trade.
|
| 06 May 2025 | Alexander (Sandy) Beard | Buy | 745,933 | $6,007 |
On-market trade.
|
| 05 May 2025 | Alexander (Sandy) Beard | Buy | 1,734,067 | $12,924 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Alexander (Sandy) Damien Harry Beard | Non-Executive ChairmanNon-Executive Director | Feb 2022 |
Mr Beard is a Investor and Investment professional focussed on driving value from small cap ASX listed companies, private equity, and earlystage investments. Previously he was CEO and MD of CVC Limited where he oversaw investment returns in excess of 15% per annum over that period.
|
| Mr Phillip Michael Christopher | Non-Executive Director | Nov 2021 |
Mr Christopher is Investment Director of Hancock and Gore Limited, responsible for advising and guiding private investments including BLC Cosmetics prior to its acquisition by Anagenics Limited. He also spent 6 years at Alceon Group where he was a director in the private equity team which made significant investments in ecommerce and proprietary brand-based businesses. Prior to that he was a member of the investment banking division of Goldman Sachs.
|
| Mr Scott Mitchell Greasley | Executive Director | Jul 2022 |
Mr Greasley has over 15 years of experience across retail, ecommerce and wholesale within the branded consumer segment. He has led successful teams transforming underperforming markets across APAC, Asia and the Middle East into highly profitable regions. His key offering is identifying and building marketleading consumer businesses that deliver significant EBITDA growth, with minimal investment. Previously, he was the CEO of Anagenics Limited leading the growth and expansion of the business via M&A activity whilst supporting day to day operations with the management team. Prior to joining Anagenics, he was Head of Greater China & Emerging Markets for Boardriders Inc based in Hong Kong, where he led the transformation of the China marketplace developing a strategic plan for the group across the region. He also spent time with the Billabong Group in Singapore and Australia, operating across all verticals of the business.
|
| Mr Hemant Amin | Company Secretary | Jun 2024 |
-
|
| Hemant Amin | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HGL Limited | 125,165,148 | 25.22% |
| Hancock & Gore Ltd | 57,504,542 | 11.59% |
| FOS Capital Limited | 35,000,000 | 7.05% |
| Hancock and Gore Limited | 24,687,500 | 4.97% |
| Dennis Eck | 18,951,483 | 3.87% |
| Mango Tree Management Pty Ltd | 13,157,895 | 2.65% |
| P & M Maguire Super Pty Ltd <P & M Maguire S/F A/C> | 12,800,000 | 2.58% |
| Vivre Investments Pty Ltd | 9,000,000 | 1.81% |
| Mr Nicholas Dermott Mcdonald | 9,000,000 | 1.81% |
| Mr Alexander Damien Beard & Mrs Pascale Marie Beard <Ad & Mp Beard | 6,195,100 | 1.25% |
| Fordholm Consultants Pty Ltd <Diana Boehme Super Fund A/C> | 6,000,000 | 1.21% |
| Direct Capital Group Pty Ltd | 5,047,305 | 1.02% |
| Mr Antony Stephen Iles | 4,608,729 | 0.93% |
| Cannington Corporation Pty Limited <Cannington Super Fund A/C> | 4,550,000 | 0.92% |
| Mr Phillip Thuaux | 4,165,952 | 0.84% |
| Mrs Aimee Kathryn Taskunas | 4,000,000 | 0.81% |
| Dr Ida Constable | 3,740,637 | 0.75% |
| Ubs Nominees Pty Ltd | 3,663,378 | 0.74% |
| Mrs Margaret Ann Ryan & Mr Micheal Rodney Ryan | 3,300,000 | 0.66% |
| Mr Alexander Beard | 3,125,000 | 0.63% |
| IQ Global Asset Partners Pty Ltd <Iq S/F A/C> | 3,059,794 | 0.56% |
